MEA Autoimmune Diagnostics Market Research Report

Share on

Middle East & Africa Autoimmune Diagnostics Market Research Report – Segmented By Test Type, Disease Type, End User and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends, Growth, Forecast (2022 to 2027)

Published: January, 2022

ID: 1130

Pages: 134

Formats:

MEA Autoimmune Diagnostics Market Size (2022 to 2027)

The size of the Middle East and Africa Autoimmune Diagnostics Market was worth USD 0.60 billion in 2022 and estimated to reach USD 0.70 billion by the end of 2027, growing at a CAGR of 3.108% between 2022 to 2027.

Autoimmune diseases are an active hyperimmune response against their own body tissues and cells. Due to mergers and acquisitions that provide an increasing opportunity in this region. The most common autoimmune diseases include rheumatoid arthritis, type 1 diabetes, and multiple sclerosis.

The Middle East & Africa market is driven by the increasing prevalence of autoimmune disorders improving healthcare infrastructure.

Cost issues and problems of skilled manpower are the factors that hinder the growth of the market.

This research report is on the Middle East and Africa Autoimmune diagnostics market has been segmented & sub-segmented into the following categories:

By Test Type:

Autoantibody Tests
Antinuclear Antibody Tests
Complete Blood Count (CBC)
C-reactive protein (CRP)
Comprehensive Metabolic panel
Urinalysis
Erythrocyte Sedimentation Rate (ESR)
Others

By Disease Type:

Localized autoimmune disease diagnostics
- Graves' Disease
- Hashimoto's Thyroiditis
- Multiple Sclerosis
- Type 1 diabetes
- Psoriasis
- Others
Systemic autoimmune disease diagnostics
- Rheumatoid Arthritis (RA)
- Ankylosing Spondylitis
- Systemic Lupus Erythematosus (SLE)

By End User:

Hospitals
Research Centres
Diagnostic Laboratories

By Country:

KSA
UAE
Israel
rest of GCC countries
South Africa
Ethiopia
Kenya
Egypt
Sudan
rest of MEA

Companies like Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly and GlaxoSmithKline Plc are playing a notable role in the MEA autoimmune diagnostics market.